{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:40:19Z","timestamp":1787020819630,"version":"build-2736575974"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,6,28]],"date-time":"2019-06-28T00:00:00Z","timestamp":1561680000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,6,28]],"date-time":"2019-06-28T00:00:00Z","timestamp":1561680000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006520","name":"Edwards Lifesciences","doi-asserted-by":"publisher","award":["not applicable"],"award-info":[{"award-number":["not applicable"]}],"id":[{"id":"10.13039\/100006520","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cardiothorac Surg"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s13019-019-0943-6","type":"journal-article","created":{"date-parts":[[2019,6,28]],"date-time":"2019-06-28T11:02:57Z","timestamp":1561719777000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Long-term outcome after mitral valve replacement using biological versus mechanical valves"],"prefix":"10.1186","volume":"14","author":[{"given":"Ayse","family":"Cetinkaya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Poggenpohl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Bramlage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Hein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirko","family":"Doss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4970-2110","authenticated-orcid":false,"given":"Peter","family":"Bramlage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Sch\u00f6nburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manfred","family":"Richter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,6,28]]},"reference":[{"key":"943_CR1","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1186\/1471-2261-14-146","volume":"14","author":"AH Ribeiro","year":"2014","unstructured":"Ribeiro AH, Wender OC, de Almeida AS, Soares LE, Picon PD. Comparison of clinical outcomes in patients undergoing mitral valve replacement with mechanical or biological substitutes: a 20 years cohort. BMC Cardiovasc Disord. 2014;14:146.","journal-title":"BMC Cardiovasc Disord"},{"key":"943_CR2","doi-asserted-by":"publisher","first-page":"2739","DOI":"10.1093\/eurheartj\/ehx391","volume":"38","author":"H Baumgartner","year":"2017","unstructured":"Baumgartner H, Falk V, Bax JJ, De Bonis M, Hamm C, Holm PJ, et al. 2017 ESC\/EACTS guidelines for the management of valvular heart disease. Eur Heart J. 2017;38:2739\u201391.","journal-title":"Eur Heart J"},{"key":"943_CR3","first-page":"e521","volume":"129","author":"RA Nishimura","year":"2014","unstructured":"Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP 3rd, Guyton RA, et al. 2014 AHA\/ACC guideline for the Management of Patients with Valvular Heart Disease: a report of the American College of Cardiology\/American Heart Association task force on practice guidelines. Circulation. 2014;129:e521\u2013643.","journal-title":"Circulation"},{"key":"943_CR4","doi-asserted-by":"publisher","first-page":"e1159","DOI":"10.1161\/CIR.0000000000000503","volume":"135","author":"RA Nishimura","year":"2017","unstructured":"Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP 3rd, Fleisher LA, et al. AHA\/ACC Focused Update of the 2014 AHA\/ACC Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2017;135:e1159\u2013e95.","journal-title":"Circulation"},{"key":"943_CR5","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1007\/s100470300005","volume":"6","author":"H Yao","year":"2003","unstructured":"Yao H, Miyamoto T, Mukai S, Yamamura M, Tanaka H, Nakagawa T, et al. Long-term results of mitral valve replacement: biological xenograft versus mechanical valves. J Artif Organs. 2003;6:30\u20136.","journal-title":"J Artif Organs"},{"key":"943_CR6","doi-asserted-by":"publisher","first-page":"2942","DOI":"10.1093\/eurheartj\/ehu365","volume":"35","author":"B Iung","year":"2014","unstructured":"Iung B, Rodes-Cabau J. The optimal management of anti-thrombotic therapy after valve replacement: certainties and uncertainties. Eur Heart J. 2014;35:2942\u20139.","journal-title":"Eur Heart J"},{"key":"943_CR7","first-page":"78","volume":"10","author":"M Demirag","year":"2001","unstructured":"Demirag M, Kirali K, Omeroglu SN, Mansuroglu D, Akinci E, Ipek G, et al. Mechanical versus biological valve prosthesis in the mitral position: a 10-year follow up of St. Jude Medical and Biocor valves. J Heart Valve Dis. 2001;10:78\u201383.","journal-title":"J Heart Valve Dis"},{"key":"943_CR8","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/S0022-5223(19)36440-2","volume":"93","author":"GL Hammond","year":"1987","unstructured":"Hammond GL, Geha AS, Kopf GS, Hashim SW. Biological versus mechanical valves. Analysis of 1,116 valves inserted in 1,012 adult patients with a 4,818 patient-year and a 5,327 valve-year follow-up. J Thorac Cardiovasc Surg. 1987;93:182\u201398.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"943_CR9","doi-asserted-by":"publisher","first-page":"91","DOI":"10.2147\/PPA.S16420","volume":"5","author":"MN Tillquist","year":"2011","unstructured":"Tillquist MN, Maddox TM. Cardiac crossroads: deciding between mechanical or bioprosthetic heart valve replacement. Patient Prefer Adherence. 2011;5:91\u20139.","journal-title":"Patient Prefer Adherence"},{"key":"943_CR10","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.117.004056","volume":"11","author":"C Fino","year":"2018","unstructured":"Fino C, Iacovoni A, Pibarot P, Pepper JR, Ferrero P, Merlo M, et al. Exercise hemodynamic and functional capacity after mitral valve replacement in patients with ischemic mitral regurgitation: a comparison of mechanical versus biological prostheses. Circ Heart Fail. 2018;11:e004056.","journal-title":"Circ Heart Fail"},{"key":"943_CR11","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1161\/CIRCULATIONAHA.113.002584","volume":"128","author":"T Kaneko","year":"2013","unstructured":"Kaneko T, Cohn LH, Aranki SF. Tissue valve is the preferred option for patients aged 60 and older. Circulation. 2013;128:1365\u201371.","journal-title":"Circulation"},{"key":"943_CR12","doi-asserted-by":"publisher","first-page":"S57","DOI":"10.1016\/S0003-4975(98)01110-2","volume":"66","author":"NC Poirer","year":"1998","unstructured":"Poirer NC, Pelletier LC, Pellerin M, Carrier M. 15-year experience with the Carpentier-Edwards pericardial bioprosthesis. Ann Thorac Surg. 1998;66:S57\u201361.","journal-title":"Ann Thorac Surg"},{"key":"943_CR13","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1067\/mtc.2002.121672","volume":"124","author":"G Dellgren","year":"2002","unstructured":"Dellgren G, David TE, Raanani E, Armstrong S, Ivanov J, Rakowski H. Late hemodynamic and clinical outcomes of aortic valve replacement with the Carpentier-Edwards Perimount pericardial bioprosthesis. J Thorac Cardiovasc Surg. 2002;124:146\u201354.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"943_CR14","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1016\/S0003-4975(01)02992-7","volume":"72","author":"MK Banbury","year":"2001","unstructured":"Banbury MK, Cosgrove DM 3rd, White JA, Blackstone EH, Frater RW, Okies JE. Age and valve size effect on the long-term durability of the Carpentier-Edwards aortic pericardial bioprosthesis. Ann Thorac Surg. 2001;72:753\u20137.","journal-title":"Ann Thorac Surg"},{"key":"943_CR15","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1016\/j.athoracsur.2010.01.046","volume":"89","author":"RS McClure","year":"2010","unstructured":"McClure RS, Narayanasamy N, Wiegerinck E, Lipsitz S, Maloney A, Byrne JG, et al. Late outcomes for aortic valve replacement with the Carpentier-Edwards pericardial bioprosthesis: up to 17-year follow-up in 1,000 patients. Ann Thorac Surg. 2010;89:1410\u20136.","journal-title":"Ann Thorac Surg"},{"key":"943_CR16","doi-asserted-by":"publisher","unstructured":"Manghelli JL, Carter DI, Khiabani AJ, Gauthier JM, Moon MR, Munfakh NA, et al. A 20-year multicenter analysis of dialysis-dependent patients who had aortic or mitral valve replacement: implications for valve selection. J Thorac Cardiovasc Surg. 2018. \n                    https:\/\/doi.org\/10.1016\/j.jtcvs.2018.10.168\n                    \n                  . Epub ahead of print.","DOI":"10.1016\/j.jtcvs.2018.10.168"},{"key":"943_CR17","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1016\/S0735-1097(00)00834-2","volume":"36","author":"K Hammermeister","year":"2000","unstructured":"Hammermeister K, Sethi GK, Henderson WG, Grover FL, Oprian C, Rahimtoola SH. Outcomes 15 years after valve replacement with a mechanical versus a bioprosthetic valve: final report of the veterans affairs randomized trial. J Am Coll Cardiol. 2000;36:1152\u20138.","journal-title":"J Am Coll Cardiol"},{"key":"943_CR18","doi-asserted-by":"publisher","first-page":"2413","DOI":"10.1016\/j.jacc.2009.10.085","volume":"55","author":"SH Rahimtoola","year":"2010","unstructured":"Rahimtoola SH. Choice of prosthetic heart valve in adults an update. J Am Coll Cardiol. 2010;55:2413\u201326.","journal-title":"J Am Coll Cardiol"},{"key":"943_CR19","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1016\/j.athoracsur.2007.12.018","volume":"85","author":"C de Vincentiis","year":"2008","unstructured":"de Vincentiis C, Kunkl AB, Trimarchi S, Gagliardotto P, Frigiola A, Menicanti L, et al. Aortic valve replacement in octogenarians: is biologic valve the unique solution? Ann Thorac Surg. 2008;85:1296\u2013301.","journal-title":"Ann Thorac Surg"},{"key":"943_CR20","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1016\/j.jtcvs.2008.09.028","volume":"137","author":"MW van Geldorp","year":"2009","unstructured":"van Geldorp MW, Eric Jamieson WR, Kappetein AP, Ye J, Fradet GJ, Eijkemans MJ, et al. Patient outcome after aortic valve replacement with a mechanical or biological prosthesis: weighing lifetime anticoagulant-related event risk against reoperation risk. J Thorac Cardiovasc Surg. 2009;137:881\u20136.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"943_CR21","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1007\/s00402-009-0930-9","volume":"130","author":"LC Borris","year":"2010","unstructured":"Borris LC. Rivaroxaban and dabigatran etexilate: two new oral anticoagulants for extended postoperative prevention of venous thromboembolism after elective total hip arthroplasty. Arch Orthop Trauma Surg. 2010;130:583\u20139.","journal-title":"Arch Orthop Trauma Surg"}],"container-title":["Journal of Cardiothoracic Surgery"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13019-019-0943-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13019-019-0943-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13019-019-0943-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,26]],"date-time":"2020-06-26T19:38:20Z","timestamp":1593200300000},"score":1,"resource":{"primary":{"URL":"https:\/\/cardiothoracicsurgery.biomedcentral.com\/articles\/10.1186\/s13019-019-0943-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,28]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["943"],"URL":"https:\/\/doi.org\/10.1186\/s13019-019-0943-6","relation":{},"ISSN":["1749-8090"],"issn-type":[{"value":"1749-8090","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,28]]},"assertion":[{"value":"27 March 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 June 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the site\u2019s Ethical Committee and complied with the Declaration of Helsinki and its amendments. Given the use of anonymised data already collected as part of routine diagnosis and treatment, written informed consent was neither feasible nor required.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Peter Bramlage received research funding from Edwards Lifesciences related and unrelated to the present work. The other authors have no conflict of interest to disclose.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"120"}}